GVK Biosciences gets bioequivalence study nod
UNI
Hyderabad, March 18
The GVK Biosciences (GVK BIO) Clinical Pharmacology Unit at Hyderabad was inspected by a three-member delegation from Ministry of Health, Turkey and approved for conducting bioequivalence studies.
The Turkish team inspected the facility and carried out a detailed audit of the facility for systems and processes meeting Good Clinical Practice (GCP) and Good Laboratory Practices (GLP) requirements, before granting the approval which will enable GVK BIO to cater to generic drug manufacturers and sellers in Turkey.
